APA (7th ed.) Citation

H, L., NX, Z., L, G., RL, Y., YY, Z., XN, H., . . . P, Z. (2026). Atractylenolide III for central nervous system disorders: A review of multi-target mechanisms and therapeutic potential. Frontiers in pharmacology, 17, 1799976. https://doi.org/10.3389/fphar.2026.1799976

Chicago Style (17th ed.) Citation

H, Li, Zeng NX, Ge L, Ye RL, Zhuang YY, Huang XN, Liang Q, Zhang JV, and Zhou P. "Atractylenolide III for Central Nervous System Disorders: A Review of Multi-target Mechanisms and Therapeutic Potential." Frontiers in Pharmacology 17 (2026): 1799976. https://doi.org/10.3389/fphar.2026.1799976.

MLA (9th ed.) Citation

H, Li, et al. "Atractylenolide III for Central Nervous System Disorders: A Review of Multi-target Mechanisms and Therapeutic Potential." Frontiers in Pharmacology, vol. 17, 2026, p. 1799976, https://doi.org/10.3389/fphar.2026.1799976.